Drugs / Tenoxicam
Tenoxicam
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT06403046 | Jun 2024 → May 2025 | temporomandibular joint disorder | Beni-Suef University | Completed | No outcome recorded |
| Phase 1/2 | NCT06572904 | Feb → Oct 2024 overdue | temporomandibular joint disorder | Mansoura University | Active not recruiting | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02549118 | Sep 2015 → Mar 2016 | obstetric disorder | Ain Shams Maternity Hospital | Unknown | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT07586072 | Aug 2024 → Aug 2025 | bruxism, myofascial pain syndrome, temporomandibular joint disorder | Recep Tayyip Erdogan University | Completed | No outcome recorded |
| Phase 4 | NCT04182191 | Mar 2018 → Jul 2019 | — | University of Sao Paulo | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07194135 | Nov 2024 → Apr 2025 | osteoarthritis, knee | Benha University | Completed | No outcome recorded |
| Comparator or background therapy9 trials | ||||||
| Phase 1 | NCT05497570 Comparator | May 2019 → Nov 2021 | hydrarthrosis | Ataturk University | Completed | No outcome recorded |
| Phase 4 | NCT07512297 Comparator | Apr → Dec 2026 expected | nephrolithiasis, ureterolithiasis | University of Gaziantep | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06786650 Comparator | May → Oct 2024 overdue | migraine disorder | Haydarpasa Numune Training and Research Hospital | Active not recruiting | No outcome recorded |
| Phase 4 | NCT02160236 Comparator | Nov 2014 → Feb 2015 | — | TC Erciyes University | Unknown | No outcome recorded |
| Phase 4 | NCT02285972 Comparator | Nov 2014 → Apr 2015 | — | Ordu University | Completed | No outcome recorded |
| — | NCT05630404 Comparator | Nov 2022 → Aug 2023 | lumbar disk degenerative disorder, lumbar spinal stenosis | Bursa City Hospital | Completed | No outcome recorded |
| — | NCT05291793 Comparator | Apr 2020 → Jul 2021 | osteoarthritis, knee | Nevsehir Haci Bektas Veli University | Completed | No outcome recorded |
| — | NCT04314310 Comparator | Mar 2020 → Dec 2022 | gastrointestinal mucositis | National Taiwan University Hospital | Unknown | No outcome recorded |
| — | NCT01638962 Comparator | Aug 2012 → Aug 2015 | osteoarthritis, knee | University of Southern Denmark | Completed | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 16 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tenoxicam | “The study aims to design a randomized controlled trial that compares the effect of intra-articular injection of the non-selective (NSAID) Tenoxicam versus the selective COX-2...” NCT06403046 ↗14“Tenoxicam 20 mg IV every 12 hours in the postoperative period.” NCT05630404 ↗ “Tenoxicam” NCT01638962 ↗ |
| Known as | EPICOTIL | “(EPICOTIL® Tenoxicam 20 mg , Manufactured by: EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES COMPANY, ReStore at a temperature not exceeding 30°C.)” NCT06572904 ↗ |
| Known as | Mobiflex | ChEMBL registry synonym — accepted as the source's own label CHEMBL302795 ↗ |
| Known as | NSC-758397 | ChEMBL registry synonym — accepted as the source's own label CHEMBL302795 ↗ |
| Known as | RO 12-0068 | ChEMBL registry synonym — accepted as the source's own label CHEMBL302795 ↗ |
| Known as | RO 12-0068/000 | ChEMBL registry synonym — accepted as the source's own label CHEMBL302795 ↗ |
| Known as | Tilcotil | ChEMBL registry synonym — accepted as the source's own label CHEMBL302795 ↗ |
| Action | Inhibit | “Tenoxicam is a nonselective (NSAID) that inhibits both COX-1 and COX-2.” NCT06403046 ↗ |
| Modality | Other / unclassified | “Tenoxicam is an NSAID that is used systemically or locally in joint diseases such as acute or chronic inflammatory rheumatoid arthritis and osteoarthritis.” NCT05497570 ↗ |
| Route | Intravenous | “via administration intravenous” NCT02160236 ↗ |